Diuretics in acute kidney injury

Minerva Anestesiologica

Volumn 75, Issue 5, 2009, Pages 251-257

  Karajala, V ^a   Mansour, W ^a   Kellum, J A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Diuretics; Dopamine; Furosemide; Kidney failure, acute; Mannitol

Indexed keywords

BICARBONATE; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT; MANNITOL; NESIRITIDE; OSMOTIC DIURETIC AGENT; PLACEBO; TORASEMIDE; BRAIN NATRIURETIC PEPTIDE;

ACUTE KIDNEY TUBULE NECROSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DIALYSIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; HEART FAILURE; HOSPITALIZATION; HUMAN; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; LUNG EDEMA; MORTALITY; MYOGLOBINURIA; NONHUMAN; NOTE; RHABDOMYOLYSIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; ACUTE KIDNEY FAILURE; ANIMAL; COHORT ANALYSIS; DISEASE MODEL; DRUG CONTRAINDICATION; FLUID THERAPY; INTENSIVE CARE; LENGTH OF STAY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; STATISTICS; TREATMENT OUTCOME; UTILIZATION REVIEW;

ANIMALS; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DIURETICS; DIURETICS, OSMOTIC; DOPAMINE; FLUID THERAPY; FUROSEMIDE; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; MANNITOL; META-ANALYSIS AS TOPIC; NATRIURETIC PEPTIDE, BRAIN; PULMONARY EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RHABDOMYOLYSIS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 67650104028     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (49)

1. Venkataraman R, Kellum JA. Prevention of acute renal failure. Chest 2007;131:300-308 (Pubitemid 46123007)
2. Kellum JA. Use of diuretics in the acute care setting. Kidney Int 1998;66:S67-70. (Pubitemid 28186131)
3. Kellum JA, Bellomo R, Ronco C. The concept of acute kidney injury and the RIFLE criteria. Contrib Nephrol 2007;156:10-16
4. Venkataraman R, Kellum JA. Acute renal failure in the critically ill. Curr Opin Anaesthesiol 2005;18:117-122 (Pubitemid 40523222)
5. Shilliday I, Allison ME. Diuretics in acute renal failure. Ren Fail 1994;16:3-17.
6. Heyman SN, Brezis M, Greenfeld Z, Rosen S. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989;14:377-385 (Pubitemid 20017575)
7. Brezis M, Rosen S, Silva P, Epstein FH. Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 1984;25:65-72. (Pubitemid 14159386)
8. Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005;31:79-85. (Pubitemid 40174285)
9. Ludens JH, Hook JB, Brody MJ, Williamson HE. Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther 1968;163:456-460
10. th ed. Milano: McGraw Hill Publishing; 2005.
11. Kellum JA. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1997;1:53-59
12. Gubern JM, Sancho JJ, Simo J, Sitges-Serra A. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 1988;103:39-44. (Pubitemid 18056208)
13. Plusa SM, Clark NW. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a comparison of mannitol-induced diuresis and oral sodium taurocholate. J R Coll Surg Edinb 1991;36:303-305
14. Ip-Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol. Anesth Analg 1994;78:842-847 (Pubitemid 24138257)
15. Powers SR, Jr., Boba A, Hostnik W, Stein A. Prevention of postoperative acute renal failure with mannitol in 100 cases. Surgery 1964;55:15-23.
16. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420 (Pubitemid 24348355)
17. Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997;19:283-288 (Pubitemid 27147238)
18. Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol 2003;284:F11-21. (Pubitemid 35471281)
19. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104. (Pubitemid 30020431)
20. Dussol B, Morange S, Loundoun A, Auquier P, Berland Y. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 2006;21:2120-2126 (Pubitemid 44295036)
21. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999;33:403-411
22. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992;62:413-5.
23. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008;148:284-94.
24. Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr 1996;126:666-73.
25. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 2002;288:2547-53.
26. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004;32:1669-77.
27. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004;44:402-9.
28. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997;12:2592-6.
29. Lumlertgul D, Keoplung M, Sitprija V, Moollaor P, Suwangool P. Furosemide and dopamine in malarial acute renal failure. Nephron 1989;52:40-4.
30. Cantarovich F, Fernandez JC, Locatelli A, Perez Loredo J. Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J 1971;47:Suppl:13-17.
31. Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol 1981;15:90-6.
32. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006;333:420.
33. Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 2007;9:60-8.
34. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-5.
35. Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J et al. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Am Heart J 2007;154:267-77.
36. Mentzer RM, Jr., Oz MC, Sladen RN, Graeve AH, Hebeler RF, Jr., Luber JM, Jr. et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 2007;49:716-26.
37. Silke B. Haemodynamic impact of diuretic therapy in chronic heart failure. Cardiology 1994;84 Suppl 2:115-23.
38. Guild SJ, Eppel GA, Malpas SC, Rajapakse NW, Stewart A, Evans RG. Regional responsiveness of renal perfusion to activation of the renal nerves. Am J Physiol Regul Integr Comp Physiol 2002;283:R1177-86.
39. Evans RG, Correia AG, Weekes SR, Madden AC. Responses of regional kidney perfusion to vasoconstrictors in anaesthetized rabbits: dependence on agent and renal artery pressure. Clin Exp Pharmacol Physiol 2000;27:1007-12.
40. Mason J, Kain H, Welsch J, Schnermann J. The early phase of experimental acute renal failure. VI. The influence of furosemide. Pflugers Arch 1981;392:125-33.
41. Dobrowolski L, Sadowski J. Furosemide-induced renal medullary hypoperfusion in the rat: role of tissue tonicity, prostaglandins and angiotensin II. J Physiol 2005;567(Pt 2):613-20.
42. Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992;89:630-9.
43. Bradley VE, Shier MR, Lucas CE, Rosenberg IK. Renal hemodynamic response to furosemide in septic and injured patients. Surgery 1976;79:549-54.
44. Epstein M, Schneider NS, Befeler B. Effect of intrarenal furosemide on renal function and intratenal hemodynarnics in acute renal failure. Am J Med 1975;58:510-6.
45. MacDonald TM, Craig K, Watson ML. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man. Br J Clin Pharmacol 1989;28:683-94.
46. Meyer P, Menard J, Papanicolaou N, Alexandre JM, Devaux C, Milliez P. Mechanism of renin release following furosemide diuresis in rabbit. Am J Physiol 1968;215:908-15.
47. Mann B, Hartner A, Jensen BL, Kammerl M, Kramer BK, Kurtz A. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 2001;59:62-8.
48. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60.
49. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354:2564-75.